These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7548277)

  • 1. Overview of regulation of gene therapy in Europe: a current statement including reference to US regulation.
    Cohen-Haguenauer O
    Hum Gene Ther; 1995 Jun; 6(6):773-85. PubMed ID: 7548277
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy: regulatory issues and international approaches to regulation.
    Cohen-Haguenauer O
    Curr Opin Biotechnol; 1997 Jun; 8(3):361-9. PubMed ID: 9206021
    [No Abstract]   [Full Text] [Related]  

  • 3. Public oversight is necessary if human gene therapy is to progress.
    Zallen DT
    Hum Gene Ther; 1996 May; 7(7):795-7. PubMed ID: 8860831
    [No Abstract]   [Full Text] [Related]  

  • 4. Trends in gene therapy regulation.
    Lecomte V; Taylor A
    Gene Ther; 1997 Feb; 4(2):77-8. PubMed ID: 11644906
    [No Abstract]   [Full Text] [Related]  

  • 5. Panel that reviews gene tests in humans has no applications.
    Weiss R
    Washington Post; 1996 Feb; ():A3. PubMed ID: 11647100
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene-splice oversight.
    Parens E
    Washington Post; 1996 Jun; ():A21. PubMed ID: 11646331
    [No Abstract]   [Full Text] [Related]  

  • 7. Reflections: of hope and of concern.
    Anderson FW
    Hum Gene Ther; 1991; 2(3):193-4. PubMed ID: 1751588
    [No Abstract]   [Full Text] [Related]  

  • 8. Fears mount for gene scrutiny as watchdog faces axe.
    Kiernan V
    New Sci; 1996 Jun; 150(2033):10. PubMed ID: 11656540
    [No Abstract]   [Full Text] [Related]  

  • 9. European debate on biotech highlights policy differences.
    Abbott A
    Nature; 1996 Jan; 379(6562):197. PubMed ID: 8538779
    [No Abstract]   [Full Text] [Related]  

  • 10. NIH guidelines for research involving recombinant DNA molecules.
    Wilson DJ
    Account Res; 1993; 3(2-3):177-85. PubMed ID: 11652293
    [No Abstract]   [Full Text] [Related]  

  • 11. Review panel cancels meeting as gene therapy proposals fall.
    Wadman M
    Nature; 1996 Feb; 379(6567):668. PubMed ID: 11644770
    [No Abstract]   [Full Text] [Related]  

  • 12. Human gene therapy and congress.
    Cook-Deegan RM
    Hum Gene Ther; 1990; 1(2):163-70. PubMed ID: 2078577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Informed consent in the clinical research setting: experimentation on human subjects.
    Owens JF
    Med Trial Tech Q; 1987; 33(3):335-50. PubMed ID: 11653829
    [No Abstract]   [Full Text] [Related]  

  • 14. The history of institutional review boards.
    Sherman M; Van Vleet JD
    Regul Aff J; 1991; 3():615-27. PubMed ID: 11651491
    [No Abstract]   [Full Text] [Related]  

  • 15. Beyond localism: a proposal for a National Research Review Board.
    Levine C; Caplan AL
    IRB; 1986; 8(2):7-9. PubMed ID: 11649751
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular medicine. One less hoop for gene therapy.
    Marshall E
    Science; 1994 Jul; 265(5172):599. PubMed ID: 8036507
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation as facilitation: negotiating the genetic revolution.
    Black J
    Mod Law Rev; 1998 Sep; 61(5):621-60. PubMed ID: 14518446
    [No Abstract]   [Full Text] [Related]  

  • 18. Overregulation is an unnecessary hindrance to human gene therapy.
    Miller HI
    Hum Gene Ther; 1995 Nov; 6(11):1361-2. PubMed ID: 8573609
    [No Abstract]   [Full Text] [Related]  

  • 19. Human gene therapy: ethics and public policy.
    Walters L
    Hum Gene Ther; 1991; 2(2):115-22. PubMed ID: 1911932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human gene therapy: application, ethics and regulation.
    Baskerville G
    Dickinson Law Rev; 1992; 96(4):733-63. PubMed ID: 11652212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.